Bio-Techne (TECH) is scheduled to report Q1 earnings on November 4, 2026. Analysts estimate EPS of $0.43 and quarterly revenue of $292.09M.
In the most recent quarter (Q4), Bio-Techne reported EPS of $0.52, beating estimates of $0.51 by 0.02%. Revenue came in at $321.19M, exceeding the estimate of $315.05M by 0.02%.
Bio-Techne has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Bio-Techne has averaged an EPS surprise of 0.06% and a revenue surprise of 0.02%.
Earnings Date
Nov 4
EPS Estimate
$0.430
Quarterly Revenue Estimate
$292.09M
Annual Revenue
$1.21B
as of Mar 31
Analyze the earnings history of Bio-Techne using advanced sorting and filters.
The chart below shows Bio-Techne's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Bio-Techne's reported revenue compared to analyst estimates over recent quarters.
Bio-Techne (TECH) is scheduled to report earnings on November 4, 2026. The last reported earnings were for reported on August 12, 2026 for Q4.
The Actual EPS was $0.52, which beat the estimate of $0.51.
The Actual Revenue was $321.19M, which beat the estimate of $315.05M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 12, 2026 | $0.52 | $0.51 | 1.96 % |
| Q3 | May 6, 2026 | $0.53 | $0.52 | 1.92 % |
| Q2 | Feb 4, 2026 | $0.46 | $0.40 | 15.0 % |
| Q1 | Nov 5, 2025 | $0.42 | $0.40 | 5.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Aug 12, 2026 | $321.19M | $315.05M | 1.95 % |
| Q3 | May 6, 2026 | $311.42M | $316.63M | -1.65 % |
| Q2 | Feb 4, 2026 | $295.88M | $291.09M | 1.64 % |
| Q1 | Nov 5, 2025 | $286.56M | $290.54M | -1.37 % |